FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition showing stress-protective action which contains peptide R1-Lys1-Arg2-Pro3-R2 [SEQ ID NO:1] or R1-Lys1-Arg2-Arg3-Pro4-R2 [SEQ ID NO:2] wherein R1=NH2 or CH3CO and R2=OH or NH2 and a method for prevention and/or treatment functional or stress-induced disorders caused by extreme factors.
EFFECT: producing the pharmaceutical composition exhibiting stress-protective action.
3 cl, 9 tbl, 7 ex
Authors
Dates
2012-07-10—Published
2009-07-02—Filed